Authors:
BJORN SF
HASTRUP N
LUND LR
DANO K
LARSEN JF
PYKE C
Citation: Sf. Bjorn et al., COORDINATED EXPRESSION OF MMP-2 AND ITS PUTATIVE ACTIVATOR, MT1-MMP, IN HUMAN PLACENTATION, Molecular human reproduction, 3(8), 1997, pp. 713-723
Authors:
BUGGE TH
DANTON MJS
DANG K
DAUGHERTY CC
DREW A
FLICK MJ
HOLMBACK K
KAO W
KOMBRINCK KW
LUND LR
PYKE C
ROMER J
STRICKLAND S
TSIRKA SE
XIAO O
DEGEN JL
Citation: Th. Bugge et al., BIOLOGICAL ROLES AND SUBSTRATES OF PLASMIN IN THE MOUSE, The FASEB journal, 11(9), 1997, pp. 3438-3438
Authors:
BJORN SF
HASTRUP N
LUND LR
DANO K
LARSEN JF
PYKE C
Citation: Sf. Bjorn et al., COORDINATED EXPRESSION OF MMP-2 AND ITS PUTATIVE ACTIVATOR, MT1-MMP, IN HUMAN PLACENTATION, The FASEB journal, 11(3), 1997, pp. 2416-2416
Citation: H. Pappot et al., LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR IN NONSMALL CELL LUNG-CANCER AS MEASURED BY QUANTITATIVE ELISA AND SEMIQUANTITATIVE IMMUNOHISTOCHEMISTRY, Lung cancer, 17(2-3), 1997, pp. 197-209
Authors:
LUND LR
ROMER J
THOMASSET N
SOLBERG H
PYKE C
BISSELL MJ
DANO K
WERB Z
Citation: Lr. Lund et al., 2 DISTINCT PHASES OF APOPTOSIS IN MAMMARY-GLAND INVOLUTION - PROTEINASE-INDEPENDENT AND PROTEINASE-DEPENDENT PATHWAYS, Development, 122(1), 1996, pp. 181-193
Authors:
GRIMMOND SM
PALMER JM
WALTERS MK
SCOTT C
NANCARROW DJ
TEH BT
ELMES C
PYKE C
KHOO SK
BENNETT I
WETZIG N
HAYWARD NK
Citation: Sm. Grimmond et al., CONFIRMATION OF A SUSCEPTIBILITY LOCUS ON CHROMOSOME-13 IN AUSTRALIANBREAST-CANCER FAMILIES, Human genetics, 98(1), 1996, pp. 80-85
Authors:
NIELSEN BS
SEHESTED M
TIMSHEL S
PYKE C
DANO K
Citation: Bs. Nielsen et al., MESSENGER-RNA FOR UROKINASE PLASMINOGEN-ACTIVATOR IS EXPRESSED IN MYOFIBROBLASTS ADJACENT TO CANCER-CELLS IN HUMAN BREAST-CANCER, Laboratory investigation, 74(1), 1996, pp. 168-177
Authors:
NIELSEN BS
TIMSHEL S
KJELDSEN L
SEHESTED M
PYKE C
BORREGAARD N
DANO K
Citation: Bs. Nielsen et al., 92 KDA TYPE-IV COLLAGENASE (MMP-9) IS EXPRESSED IN NEUTROPHILS AND MACROPHAGES BUT NOT IN MALIGNANT EPITHELIAL-CELLS IN HUMAN COLON-CANCER, International journal of cancer, 65(1), 1996, pp. 57-62
Citation: Lr. Lund et al., TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION OF THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BY CYTOKINES AND TUMOR PROMOTERS IN THE HUMAN LUNG-CARCINOMA CELL-LINE A549, Biochemical journal, 310, 1995, pp. 345-352
Authors:
PAPPOT H
GARDSVOLL H
ROMER J
PEDERSEN AN
GRONDAHLHANSEN J
PYKE C
BRUNNER N
Citation: H. Pappot et al., PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN CANCER - THERAPEUTIC AND PROGNOSTIC IMPLICATIONS, Biological chemistry Hoppe-Seyler, 376(5), 1995, pp. 259-267
Citation: H. Ohtani et al., EXPRESSION OF UROKINASE RECEPTOR IN VARIOUS STROMAL-CELL POPULATIONS IN HUMAN COLON-CANCER - IMMUNOELECTRON MICROSCOPIC ANALYSIS, International journal of cancer, 62(6), 1995, pp. 691-696
Authors:
PYKE C
SALE S
RALFKIAER E
ROMER J
DANO K
TRYGGVASON K
Citation: C. Pyke et al., LAMININ-5 IS A MARKER OF INVADING CANCER-CELLS IN SOME HUMAN CARCINOMAS AND IS COEXPRESSED WITH THE RECEPTOR FOR UROKINASE PLASMINOGEN-ACTIVATOR IN BUDDING CANCER-CELLS IN COLON ADENOCARCINOMAS, Cancer research, 55(18), 1995, pp. 4132-4139
Authors:
PYKE C
RALFKIAER E
RONNE E
HOYERHANSEN G
KIRKEBY L
DANO K
Citation: C. Pyke et al., IMMUNOHISTOCHEMICAL DETECTION OF THE RECEPTOR FOR UROKINASE PLASMINOGEN-ACTIVATOR IN HUMAN COLON-CANCER, Histopathology, 24(2), 1994, pp. 131-138
Authors:
DANO K
BEHRENDT N
BRUNNER N
ELLIS V
PLOUG M
PYKE C
Citation: K. Dano et al., THE UROKINASE RECEPTOR - PROTEIN-STRUCTURE AND ROLE IN PLASMINOGEN ACTIVATION AND CANCER INVASION, Fibrinolysis, 8, 1994, pp. 189-203
Authors:
ROMER J
LUND LR
ERIKSEN J
PYKE C
KRISTENSEN P
DANO K
Citation: J. Romer et al., THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IS EXPRESSED BYKERATINOCYTES AT THE LEADING SKIN DURING REEPITHILIALIZATION, Journal of investigative dermatology, 102(4), 1994, pp. 519-522
Authors:
ROMER J
PYKE C
LUND LR
ERIKSEN J
KRISTENSEN P
RONNE E
HOYERHANSEN G
DANO K
BRUNNER N
Citation: J. Romer et al., EXPRESSION OF UPA AND ITS RECEPTOR BY BOTH NEOPLASTIC AND STROMAL CELLS DURING XENOGRAFT INVASION, International journal of cancer, 57(4), 1994, pp. 553-560
Authors:
WERNERT N
GILLES F
FAFEUR V
BOUALI F
RAES MB
PYKE C
DUPRESSOIR T
SEITZ G
VANDENBUNDER B
STEHELIN D
Citation: N. Wernert et al., STROMAL EXPRESSION OF C-ETS1 TRANSCRIPTION FACTOR CORRELATES WITH TUMOR INVASION, Cancer research, 54(21), 1994, pp. 5683-5688
Authors:
WERNERT N
GILLES F
FAFEUR V
BOUALI F
RAES MB
PYKE C
DUPRESSOIR T
SEITZ G
VANDENBUNDER B
STEHELIN D
Citation: N. Wernert et al., STROMAL EXPRESSION OF C-ETS1 TRANSCRIPTION FACTOR CORRELATES WITH TUMOR INVASION, Cancer research, 54(21), 1994, pp. 5683-5688
Authors:
PYKE C
ROMER J
KALLUNKI P
LUND LR
RALFKIAER E
DANO K
TRYGGVASON K
Citation: C. Pyke et al., THE GAMMA-2-CHAIN OF KALININ LAMININ-5 IS PREFERENTIALLY EXPRESSED ININVADING MALIGNANT-CELLS IN HUMAN CANCERS/, The American journal of pathology, 145(4), 1994, pp. 782-791
Authors:
PLESNER T
RALFKIAER E
WITTRUP M
JOHNSEN H
PYKE C
PEDERSEN TL
HANSEN NE
DANO K
Citation: T. Plesner et al., EXPRESSION OF THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN NORMAL AND NEOPLASTIC BLOOD-CELLS AND HEMATOPOIETIC-TISSUE, American journal of clinical pathology, 102(6), 1994, pp. 835-841
Authors:
PYKE C
ERIKSEN J
SOLBERG H
NIELSEN BS
KRISTENSEN P
LUND LR
DANO K
Citation: C. Pyke et al., AN ALTERNATIVELY SPLICED VARIANT OF MESSENGER-RNA FOR THE HUMAN RECEPTOR FOR UROKINASE PLASMINOGEN-ACTIVATOR, FEBS letters, 326(1-3), 1993, pp. 69-74